LIPI.ST Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 apr 2024 @ 17:29):

Lipidor AB (publ), a pharmaceutical development company, engages in the development of drugs for the treatment of psoriasis, bacterial skin infections, and atopic dermatitis...

Stats
Dagens volum	71 781.00
Gjennomsnittsvolum	223 086
Markedsverdi	6.81M
EPS	SEK-0.100 ( 2023-11-22 )
Neste inntjeningsdato	( SEK0 ) 2024-06-07
Last Dividend	SEK0 ( N/A )
Next Dividend	SEK0 ( N/A )
P/E	-0.450
ATR14	SEK0.0120 (5.11%)

Lipidor AB (publ) Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Lipidor AB (publ) Økonomi

Annual	2023
Omsetning:	SEK78 000.00
Bruttogevinst:	SEK-15.46M (-19 824.36 %)
EPS:	SEK-0.400

FY	2023
Omsetning:	SEK78 000.00
Bruttogevinst:	SEK-15.46M (-19 824.36 %)
EPS:	SEK-0.400

FY	2022
Omsetning:	SEK45 000.00
Bruttogevinst:	SEK-41.72M (-92 704.44 %)
EPS:	SEK-1.420

FY	2021
Omsetning:	SEK15.38M
Bruttogevinst:	SEK0.00 (0.00 %)
EPS:	SEK-0.750

Financial Reports:

No articles found.

Lipidor AB (publ)

Lipidor AB (publ), a pharmaceutical development company, engages in the development of drugs for the treatment of psoriasis, bacterial skin infections, and atopic dermatitis. The company develops AKP-01, which is in Phase III for the treatment of psoriasis; and preclinical stage products, such as AKP-02 for psoriasis, and AKP-03 AKP-07 for eczema. It offers active pharmaceutical ingredients used in products for various therapeutic applications, such as anti-psoriasic, antimicrobial, anti-inflammatory, antifungal, local anesthetics, non-steroidal anti-inflammatory, anti-acne, wound healing, anti-eczema, and anti-migraine. The company also develops a range of spray products for animal skin care in dogs, cats, and horses; and consumer health care products for applications, including antibacterial, antiseptic, moisturizing emollient, disinfectant, and acne and wart treatment. It has a collaboration agreement with Cannassure Therapeutics Ltd. for the development of topical medicinal cannabis products for the treatment of skin inflammations and psoriatic lesions. The company was incorporated in 2009 and is based in Danderyd, Sweden.